The clinical information you need, at your fingertips.

Medical News for You

Endocr Pract

AACE calls for broader access to diabetes technology

New consensus supports CGM for most adults with diabetes and expands automated insulin delivery beyond traditional eligibility limits. . .

Radiology

Where patients live may matter for brain aging

Routine clinical MRI data link neighborhood disadvantage to lower tissue volume and signs of vascular injury. . .

Ann Intern Med

Latest VA/DoD cholesterol guideline broadens risk checks, steps up therapy

PREVENT, selective CAC scoring, and one-time Lp(a) testing anchor a more personalized approach, with intensified lipid lowering for the highest-risk patients. . .

Drug pipeline

Etcamah falls short in phase 3 trial of broader first-line use for advanced breast cancer

Negative result in patients starting first-line therapy contrasts with the drug’s newly approved use after an ESR1 mutation develops during treatment. . .

Pregnancy

When abortion access is limited: New SMFM guidance for high-risk pregnancies

New special statement urges maternal-fetal medicine specialists to strengthen counseling, referral pathways, and institutional protocols to preserve access to evidence-based reproductive care. . .

Ann Intern Med

17h

New anemia guideline backs personalized treatment, favors IV iron in dialysis

Updated KDIGO recommendations emphasize individualized ESA use, cautious adoption of HIF-PHIs, and proactive iron management in CKD. . .

Ann Intern Med

20h

Veterinary sedative in fentanyl tied to severe withdrawal

Patients describe medetomidine withdrawal as worse than fentanyl or xylazine withdrawal, with usual care proving ineffective to mitigate it. . .

FDA

21h

FDA approves Isembyld, first spinal muscular atrophy therapy to directly target muscle loss

The add-on treatment offers a new approach for patients with persistent weakness despite therapies that preserve motor neurons. . .

JAMA Pediatr

Autism rates hold steady, challenging ‘epidemic’ claims

Population-wide screening found no rise in autism incidence or prevalence across 12 birth cohorts. . .